ETF Managers Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,649
| Closed | -$289K | – | 710 |
|
|
2022
Q4 | $289K | Buy |
+7,649
| New | +$289K | 0.01% | 443 |
|
|
2021
Q2 | – | Sell |
-6,975
| Closed | -$312K | – | 730 |
|
|
2021
Q1 | $312K | Buy |
6,975
+938
| +16% | +$42K | 0.01% | 587 |
|
|
2020
Q4 | $345K | Buy |
6,037
+679
| +13% | +$38.8K | 0.01% | 523 |
|
|
2020
Q3 | $260K | Buy |
5,358
+265
| +5% | +$12.9K | 0.01% | 539 |
|
|
2020
Q2 | $303K | Buy |
5,093
+1,698
| +50% | +$101K | 0.01% | 408 |
|
|
2020
Q1 | $164K | Buy |
3,395
+348
| +11% | +$16.8K | 0.01% | 490 |
|
|
2019
Q4 | $184K | Buy |
3,047
+703
| +30% | +$42.5K | 0.01% | 519 |
|
|
2019
Q3 | $138K | Buy |
2,344
+46
| +2% | +$2.71K | 0.01% | 514 |
|
|
2019
Q2 | $149K | Sell |
2,298
-949
| -29% | -$61.5K | ﹤0.01% | 517 |
|
|
2019
Q1 | $264K | Buy |
3,247
+291
| +10% | +$23.7K | 0.01% | 271 |
|
|
2018
Q4 | $160K | Buy |
2,956
+402
| +16% | +$21.8K | 0.01% | 313 |
|
|
2018
Q3 | $132K | Buy |
2,554
+268
| +12% | +$13.9K | 0.01% | 335 |
|
|
2018
Q2 | $1.3K | Buy |
2,286
+537
| +31% | +$304 | 0.09% | 112 |
|
|
2018
Q1 | $74K | Buy |
1,749
+218
| +14% | +$9.22K | ﹤0.01% | 412 |
|
|
2017
Q4 | $75K | Buy |
1,531
+218
| +17% | +$10.7K | 0.01% | 335 |
|
|
2017
Q3 | $67K | Buy |
1,313
+109
| +9% | +$5.56K | 0.01% | 178 |
|
|
2017
Q2 | $61K | Buy |
+1,204
| New | +$61K | 0.01% | 221 |
|
|
2016
Q1 | $26K | Buy |
+652
| New | +$26K | 0.02% | 404 |
|